Lataa...
Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo
1. Previous studies investigating the role of metabotropic glutamate (mGlu) receptors in nociceptive processing have been hampered by the lack of systemically active, selective, ligands. This study investigates the possible analgesic and/or anti-hyperalgesic properties of the most potent compound to...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2002
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1573247/ https://ncbi.nlm.nih.gov/pubmed/11877334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0704583 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|